✦ LIBER ✦

Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials

✍ Scribed by Dennis Slamon; Mark Pegram

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ongoing adjuvant trials with trastuzumab

✍ Antoinette R Tan; Sandra M Swain 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Docetaxel (Taxotere) plus trastuzumab (H

✍ Howard A Burris III 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 784 KB

Cardiac toxicity of trastuzumab (Hercept

✍ Joseph A Sparano 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 879 KB

Adjuvant trastuzumab for HER2-positive b

✍ James Spicer; Mark Harries; Paul Ellis 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 47 KB

P176 Cardiac safety guidelines for the a

✍ M.S. Ewer; E.A. Perez; J. Baselga; R. Bell; D. Brutsaert; M. Marty; T. Pienkowsk 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Trastuzumab in adjuvant therapy for earl

✍ Steven J. Tucker 📂 Article 📅 2005 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 133 KB